OSI Pharmaceuticals, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for OSI Pharmaceuticals, LLC.The latest application filed is for "pulse dosing regimen and methods of treatment".

Company Profile

5.42.39

OSI Pharmaceuticals, LLC - Northbrook IL US
OSI Pharmaceuticals, LLC - Farmingdale NY
OSI Pharmaceuticals, LLC - Melville NY US
OSI Pharmaceuticals ,LLC -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Pulse Dosing Regimen And Methods Of Treatment App 20220133725 - Gill; Stanley C. ; et al.	2022-05-05
Pulse dosing regimen and methods of treatment Grant 11,253,520 - Gill , et al. February 22, 2	2022-02-22
Pulse Dosing Regimen And Methods Of Treatment App 20200230142 - Gill; Stanley C. ; et al.	2020-07-23
Pulse dosing regimen and methods of treatment Grant 10,583,142 - Gill , et al.	2020-03-10
Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment Grant 9,896,730 - Kan , et al. February 20, 2	2018-02-20
Pulse Dosing Regimen And Methods Of Treatment App 20170273982 - GILL; Stanley C. ; et al.	2017-09-28
Processes for the preparation of isothiazole derivatives Grant 9,371,298 - Damon , et al. June 21, 2	2016-06-21
Biological Markers Predictive Of Anti-cancer Response To Epidermal Growth Factor Receptor Kinase Inhibitors App 20160158235 - HALEY; John D. ; et al.	2016-06-09
Substituted pteridinones for the treatment of cancer Grant 9,351,974 - Jin , et al. May 31, 2	2016-05-31
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors Grant 9,244,058 - Haley , et al. January 26, 2	2016-01-26
Macrocyclic kinase inhibitors Grant 9,133,224 - Crew , et al. September 15, 2	2015-09-15
Amino pyrimidine anticancer compounds Grant 9,096,624 - Crew , et al. August 4, 2	2015-08-04
Processes For The Preparation Of Isothiazole Derivatives App 20150065726 - Damon; David B. ; et al.	2015-03-05
Dihydropteridinones App 20140315911 - Jin; Meizhong ; et al.	2014-10-23
Fused bicyclic mTOR inhibitors Grant 8,796,455 - Chen , et al. August 5, 2	2014-08-05
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,735,405 - Arnold , et al. May 27, 2	2014-05-27
Fused Bicyclic Kinase Inhibitors App 20140088114 - Jin; Meizhong ; et al.	2014-03-27
Methods For The Identification Of Agents That Inhibit Mesenchymal-like Tumor Cells Or Their Formation App 20140057352 - Kan; Julie	2014-02-27
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,653,268 - Mulvihill , et al. February 18, 2	2014-02-18
Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation Grant 8,642,834 - Kan , et al. February 4, 2	2014-02-04
Biological Markers Predictive Of Anti-cancer Response To Epidermal Growth Factor Receptor Kinase Inhibitors App 20140018375 - Haley; John D. ; et al.	2014-01-16
Substituted pyrrolo[2,3-b]-pyridines and -pyrazines Grant 8,592,448 - Chen , et al. November 26, 2	2013-11-26
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Grant 8,586,546 - Buck , et al. November 19, 2	2013-11-19
Combination cancer therapy Grant 8,575,164 - Arnold , et al. November 5, 2	2013-11-05
mTOR inhibitor salt forms Grant 8,557,814 - Castelhano , et al. October 15, 2	2013-10-15
Macrocyclic Kinase Inhibitors App 20130261086 - Crew; Andrew P. ; et al.	2013-10-03
Preparation Of C-pyrazine-methylamines App 20130261306 - Mao; Yunyu ; et al.	2013-10-03
Fused Bicyclic Kinase Inhibitors App 20130253197 - Mulvihill; Mark J. ; et al.	2013-09-26
Amino Pyrimidine Anticancer Compounds App 20130231306 - CREW; Andrew P. ; et al.	2013-09-05
Preparation of C-pyrazine-methylamines Grant 8,513,415 - Mao , et al. August 20, 2	2013-08-20
Biological Markers Predictive Of Anti-cancer Response To Kinase Inhibitors App 20130210026 - HALEY; John D. ; et al.	2013-08-15
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20130190496 - Mulvihill; Mark J. ; et al.	2013-07-25
Substituted imidazopyr- and imidazotri-azines Grant 8,481,733 - Crew , et al. July 9, 2	2013-07-09
FUSED BICYCLIC mTOR INHIBITORS App 20130165651 - Chen; Xin ; et al.	2013-06-27
Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation Grant 8,465,912 - Kan June 18, 2	2013-06-18
Pet Imaging App 20130137975 - Bugaj; Joseph E. ; et al.	2013-05-30
Fused bicyclic kinase inhibitors Grant 8,445,510 - Mulvihill , et al. May 21, 2	2013-05-21
Fused Bicyclic Kinase Inhibitors App 20130072495 - Li; An-Hu ; et al.	2013-03-21
Amino pyrimidine anticancer compounds Grant 8,399,433 - Appari , et al. March 19, 2	2013-03-19
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors Grant 8,388,957 - Haley March 5, 2	2013-03-05
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors Grant 8,383,357 - Haley , et al. February 26, 2	2013-02-26
7-aminofuropyridine derivatives Grant 8,378,104 - Hornberger , et al. February 19, 2	2013-02-19
Biological markers predictive of anti-cancer response to kinase inhibitors Grant 8,377,636 - Haley , et al. February 19, 2	2013-02-19
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,367,826 - Laufer , et al. February 5, 2	2013-02-05
Combination Anti-cancer Therapy App 20130005733 - Barr; Sharon ; et al.	2013-01-03
Substituted-5-aminopyrrolo/pyrazolopyridines App 20120329826 - Li; An-Hu ; et al.	2012-12-27
Fused bicyclic motor inhibitors Grant 8,314,111 - Chen , et al. November 20, 2	2012-11-20
Deuterated Tyrosine Kinase Inhibitors App 20120220595 - Epstein; David M. ; et al.	2012-08-30
Biological Markers Predictive Of Anti-cancer Response To Insulin-like Growth Factor-1 Receptor Kinase Inhibitors In Hepatocellular Carcinoma App 20120214830 - Buck; Elizabeth A. ; et al.	2012-08-23
Combined Treatment with an EGFR Kinase Inhibitor and an Agent that Sensitizes Tumor Cells to the Effects of EGFR Kinase Inhibitors App 20120207767 - Buck; Elizabeth A. ; et al.	2012-08-16
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20120196847 - Arnold; Lee D. ; et al.	2012-08-02
Combination Anti-cancer Therapy App 20120189641 - Buck; Elizabeth A. ; et al.	2012-07-26
Biological Markers Predictive Of Anti-cancer Response To Epidermal Growth Factor Receptor Kinase Inhibitors App 20120142028 - Richardson; Frank C. ; et al.	2012-06-07
mTOR INHIBITOR AND ANGIOGENESIS INHIBITOR COMBINATION THERAPY App 20120128670 - Barr; Sharon M. ; et al.	2012-05-24
Biological Markers Predictive Of Anti-Cancer Response To Insulin-like Growth Factor-1 Receptor Kinase Inhibitors App 20120122841 - Haley; John D.	2012-05-17
2-aminopyridine kinase inhibitors Grant 8,178,668 - Steinig , et al. May 15, 2	2012-05-15
Biological Markers Predictive of Anti-Cancer Response to Insulin-Like Growth Factor-1 Receptor Kinase Inhibitors App 20120101084 - Haley; John D. ; et al.	2012-04-26
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20120077979 - Arnold; Lee D. ; et al.	2012-03-29
Preparation of C-Pyrazine-Methylamines App 20120041202 - Mao; Yunyu ; et al.	2012-02-16
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Grant 8,114,846 - Buck , et al. February 14, 2	2012-02-14
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,101,613 - Arnold , et al. January 24, 2	2012-01-24
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors Grant 8,062,838 - Haley November 22, 2	2011-11-22
Fused Bicyclic Kinase Inhibitors App 20110281888 - Mulvihill; Mark J. ; et al.	2011-11-17
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors Grant 8,048,621 - Haley , et al. November 1, 2	2011-11-01
Furo[3,2-C]pyridines Grant 8,022,206 - Li , et al. September 20, 2	2011-09-20
Substituted Pyrrolo[2,3-b]-Pyridines and -Pyrazines App 20110224191 - Chen; Xin ; et al.	2011-09-15
Fused Bicyclic mTOR Inhibitors App 20110218183 - Chen; Xin ; et al.	2011-09-08
Integrin antagonists useful as anticancer agents Grant 8,003,806 - Bloxham , et al. August 23, 2	2011-08-23
Inhibition of EMT induction in tumor cells by anti-cancer agents Grant 7,998,688 - Shaaban , et al. August 16, 2	2011-08-16
Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitor Grant 7,951,405 - Higgins , et al. May 31, 2	2011-05-31